<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">pmedpharm</journal-id><journal-title-group><journal-title xml:lang="ru">Фармация и фармакология</journal-title><trans-title-group xml:lang="en"><trans-title>Pharmacy &amp; Pharmacology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2307-9266</issn><issn pub-type="epub">2413-2241</issn><publisher><publisher-name>Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical Univer</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.19163/2307-9266-2019-7-6-332-338</article-id><article-id custom-type="elpub" pub-id-type="custom">pmedpharm-553</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ФАРМАКОЛОГИЯ И КЛИНИЧЕСКАЯ ФАРМАКОЛОГИЯ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>PHARMACOLOGY AND CLINICAL PHARMACOLOGY</subject></subj-group></article-categories><title-group><article-title>Церебропротективное действие некоторых фенолокислот в условиях экспериментальной ишемии головного мозга</article-title><trans-title-group xml:lang="en"><trans-title>Сerebroprotective effect of some phenolic acids under conditions of experimental brain ischemia</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6638-6223</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Воронков</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Voronkov</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Воронков Андрей Владиславович – доктор медицинских наук, профессор, заведующий кафедрой фармакологии с курсом клинической фармакологии</p><p>357532, Россия, г. Пятигорск, пр. Калинина, 11</p></bio><bio xml:lang="en"><p>Andrey V. Voronkov – Doctor of Science (Medicine), professor, the Head of the department of pharmacology with a course of clinical pharmacology</p><p>11, Kalinin ave., Pyatigorsk, Russia 357532</p></bio><email xlink:type="simple">prohor77@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-0889-7855</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поздняков</surname><given-names>Д. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Pozdnyakov</surname><given-names>D. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Поздняков Дмитрий Игоревич – кандидат фармацевтических наук, старший преподаватель, кафедра фармакологии с курсом клинической фармакологии</p><p>357532, Россия, г. Пятигорск, пр. Калинина, 11</p></bio><bio xml:lang="en"><p>Dmitry I. Pozdnyakov – Candidate of Sciences (Pharmacy), Senior Lecturer of the Department of Pharmacology with a course of clinical pharmacology</p><p>11, Kalinin ave., Pyatigorsk, Russia 357532</p></bio><email xlink:type="simple">pozdniackow.dmitry@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9898-0518</contrib-id><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нигарян</surname><given-names>С. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Nigaryan</surname><given-names>S. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Нигарян Сирануш Артуровна – аспирант, кафедра фармакологии с курсом клинической фармакологии</p><p>357532, Россия, г. Пятигорск, пр. Калинина, 11</p></bio><bio xml:lang="en"><p>Siranush A. Nigaryan – postgraduatestudentof the department of pharmacology with a course of clinical pharmacology</p><p>11, Kalinin ave., Pyatigorsk, Russia 357532</p></bio><email xlink:type="simple">79682650210@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>Пятигорский медико-фармацевтический институт – филиал ФГБОУ ВО «Волгоградский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Pyatigorsk Medical and Pharmaceutical Institute – branch of Volgograd State Medical University</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2019</year></pub-date><pub-date pub-type="epub"><day>16</day><month>01</month><year>2020</year></pub-date><volume>7</volume><issue>6</issue><fpage>332</fpage><lpage>339</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Воронков А.В., Поздняков Д.И., Нигарян С.А., 2020</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="ru">Воронков А.В., Поздняков Д.И., Нигарян С.А.</copyright-holder><copyright-holder xml:lang="en">Voronkov A.V., Pozdnyakov D.I., Nigaryan S.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.pharmpharm.ru/jour/article/view/553">https://www.pharmpharm.ru/jour/article/view/553</self-uri><abstract><p>Цель исследования – изучить церебропротективную активность некоторых фенолокислот в условиях экспериментальной ишемии головного мозга у крыс.</p><sec><title>Материалы и методы</title><p>Материалы и методы. Эксперимент был проведен на крысах-самцах линии Wistar, массой 220–240 г. Фокальную ишемию головного мозга моделировали путем необратимой правосторонней термокоагуляции средней мозговой артерии под хлоралгидратным наркозом (350 мг/кг, интарперитонеально). Экспериментальные соединения (4-гидрокси-3,5-ди-трет-бутилкоричная кислота, кофейная кислота и галловая кислота 100 мг/кг каждое соединение) и референтные препараты (Мексикор – 100 мг/кг, Холина альфосцерат – 150 мг/кг) вводили на следующие сутки после операции интрагастрально и далее в течении трех дней. Влияние соединений на когнитивные функции крыс оценивали в тестах «условная реакция пассивного избегания» (УРПИ) и тесте экстраполяционного избавления (ТЭИ). Изучалось влияние данных соединений на изменение концентрации лактата, пирувата, гомоцистеина, а также степень формирования отека и некроза мозговой ткани.</p></sec><sec><title>Результаты</title><p>Результаты. Установлено, что на фоне фокальной ишемии головного мозга применение кофейной, 4-гидрокси-3,5-ди-трет-бутилкоричной и галловой кислот способствовало сохранению памятного следа у крыс, а также снижению концентрации лактата (на 40,37% (р&lt;0,05), 151,26% (р&lt;0,05), 48,02% (р&lt;0,05)) и пирувата (на 96,6,% (р&lt;0,05), 38,78% (р&lt;0,05), 33,3% (р&lt;0,05)), гомоцистеина (на 59,6%(р&lt;0,05), 102,18% (р&lt;0,05), 28,8% (р&lt;0,05)), зоны некроза (на 122,79% (р&lt;0,05), 165,11% (р&lt;0,05), 12,38% (р&lt;0,05)) и отека (на 10,47% (р&lt;0,05), 11,08% (р&lt;0,05), 9,92% (р&lt;0,05)) относительно группы крыс негативного контроля (НК).</p></sec><sec><title>Заключение</title><p>Заключение. Результаты экспериментальных данных свидетельствуют о возможности дальнейшего углубленного изучения 4-гидрокси-3,5-ди-трет-бутилкоричной, кофейной, галловой кислот на предмет церебропротективной активности.</p></sec></abstract><trans-abstract xml:lang="en"><p>The aim of the study was to evaluate the cerebroprotective effect of some phenolic acids under the conditions of experimental cerebral ischemia in rats.</p><sec><title>Materials and methods</title><p>Materials and methods. The experiment was conducted on male Wistar rats weighing 220–240 g. Focal cerebral ischemia was modeled by irreversible right-sided thermocoagulation of the middle cerebral artery under chloral hydrate anesthesia (350 mg/kg, intraperitoneally). The experimental compounds (4-hydroxy-3.5-di-tert-butyl cinnamic acid, caffeic acid and gallic acid 100 mg/kg each compound) and a reference drug (Mexicor – 100 mg/kg) were administered intragastrically next day after the surgery and then for three daysrunning. The effect of the test-compounds on the cognitive functions of the rats was evaluated by CRPA and TEA tests. The influence of the compounds on the changes in the concentration of lactate, pyruvate, homocysteine, as well as the degree of cerebral edema formation and necrosis of the brain tissue, were studied.</p></sec><sec><title>Results</title><p>Results. In the study, it has been established that against the background of the focal cerebral ischemia, the administration of caffeic, 4-hydroxy-3,5-di-tert-butylcinnamic and gallic acid, contributed to the preservation of a memorable trace in rats, as well as a decrease in lactate concentration (by 40.37% (p&lt;0.05), 151.26% (p&lt;0.05), 48.02% (p&lt;0.05)) and pyruvate (by 96.6,% (p&lt;0.05), 38, 78% (p&lt;0.05), 33.3% (p&lt;0.05)), homocysteine (by 59.6% (p&lt;0.05), 102.18% (p&lt;0.05), 28.8% (p&lt;0.05)), аnecrosis zone (by 122.79% (p&lt;0.05), 165.11% (p&lt;0.05), 12.38% (p&lt;0,05)) and cerebral edema (by 10.47% (p&lt;0.05), 11.08% (p&lt;0.05), 9.92% (p&lt;0.05)) relative to the NC group of rats.</p></sec><sec><title>Conclusion</title><p>Conclusion. The obtained data indicate the possibility of further detailed investigation of the cerebroprotective effect of 4-hydroxy-3,5-di-tert-butylcinnamic, caffeic and gallic acids.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>ишемия головного мозга</kwd><kwd>инсульт</kwd><kwd>лактат</kwd><kwd>пируват</kwd><kwd>кофейная кислота</kwd><kwd>галловая кислота</kwd><kwd>4-гидрокси-3</kwd><kwd>5-ди-трет-бутилкоричная кислота</kwd><kwd>этилметилгидроксипиридина сукцинат</kwd><kwd>холина альфосцерат</kwd></kwd-group><kwd-group xml:lang="en"><kwd>cerebral ischemia</kwd><kwd>an insult to the brain</kwd><kwd>lactate</kwd><kwd>pyruvate</kwd><kwd>caffeic acid</kwd><kwd>gallic acid</kwd><kwd>4-hydroxy-3</kwd><kwd>5-di-tert-butylcinnamic acid</kwd><kwd>ethylmethylhydroxypyridine succinate</kwd><kwd>choline alfoscerate</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Adeloye D. An estimate of the incidence and prevalence of stroke in Africa: a systematic review and meta-analysis // PLoS One. – 2014. – Vol. 9, N 6 (e100724). doi: 10.1371/journal.pone.0100724.</mixed-citation><mixed-citation xml:lang="en">Adeloye D. An estimate of the incidence and prevalence of stroke in Africa: a systematic review and meta-analysis. PLoS One. 2014; 9(6): e100724. DOI: 10.1371/journal.pone.0100724.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Feigin V.L., Roth G.A., Naghavi M., Parmar P., Krishnamurthi R., Chugh S., Mensah G.A., Norrving B., Shiue I., Ng M., Estep K., Cercy K., Murray C.J.L., Forouzanfar M.H.; Global Burden of Diseases, Injuries and Risk Factors Study 2013 and Stroke Experts Writing Group. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 // Lancet Neurol. – 2016. – Vol. 15, №9. – Р. 913–924. DOI:10.1016/S1474-4422(16)30073-4.</mixed-citation><mixed-citation xml:lang="en">Feigin VL, Roth GA, Naghavi M, Parmar P, Krishnamurthi R, Chugh S, Mensah GA, Norrving B, Shiue I, Ng M, Estep K, Cercy K, Murray CJL, Forouzanfar MH. Global Burden of Diseases, Injuries and Risk Factors Study 2013 and Stroke Experts Writing Group. Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet Neurol. 2016; 15(9): 913–24. DOI:10.1016/S14744422(16)30073-4.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Кузнецов В.В., Шульженко Д.В., Романюк Т.Ю., Довгопола Т.М. Комбинированная нейрометаболическая терапия больных, перенесших ишемический инсульт // ЖУРНАЛ НЕВРОЛОГІЇ ім. Б.М. Маньковського. – 2016. – Т. 4, №3. – С. 69–75.</mixed-citation><mixed-citation xml:lang="en">Kuznecov VV, SHul’zhenko DV, Romanyuk TYU, Dovgopola TM. Kombinirovannaya neĭrometabolicheskaya terapiya bol’nyh, perenesshih ishemicheskiĭ insul’t. [Combined neurometabolic therapy in ischemic stroke patients] The Journal оf Neuroscience of B.M. Mankovskyi. 2016;4(3):69–75. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Mestre H., Cohen-Minian Y., Zajarias-Fainsod D., Ibarra A. (May 15th 2013). Pharmacological Treatment of Acute Ischemic Stroke. DOI: 10.5772/53774. Available from: https://www.intechopen.com/books/neurodegenerative-diseases/pharmacologicaltreatment-of-acute-ischemic-stroke</mixed-citation><mixed-citation xml:lang="en">Mestre H, Cohen-Minian Y, Zajarias-Fainsod D, Ibarra A. (May 15th 2013). Pharmacological Treatment of Acute Ischemic Stroke. DOI: 10.5772/53774. Available from: https://www.intechopen.com/books/neurodegenerative-diseases/pharmacological-treatment-of-acute-ischemic-stroke.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Radaelli A., Mancia G., Ferrarese C., Beretta S. (Eds.), Current Developments in Stroke, BENTHAM SCIENCE PUBLISHERS. – 2017. DOI:10.2174/97816810842131170101.</mixed-citation><mixed-citation xml:lang="en">Radaelli A, Mancia G, Ferrarese C, Beretta S (Eds.), Current Developments in Stroke, BENTHAM SCIENCE PUBLISHERS. 2017. DOI:1 0.2174/97816810842131170101.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Woodruff T.M., Thundyil J., Tang S.C., Sobey C.G., Taylor S.M., Arumugam T.V. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke // Mol Neurodegener. – 2011. – Vol. 6, №1. – Р.11. DOI:10.1186/1750-1326-6-11.</mixed-citation><mixed-citation xml:lang="en">Woodruff TM, Thundyil J, Tang SC, Sobey CG, Taylor SM, Arumugam TV. Pathophysiology, treatment, and animal and cellular models of human ischemic stroke. Mol Neurodegener. 2011; 6(1):11. DOI:10.1186/1750-1326-6-11.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Crupi R., Di Paola R., Esposito E., Cuzzocrea S. Middle cerebral artery occlusion by an intraluminal suture method // Methods Mol. Biol. – 2018. – Vol. 1727. – P. 393–401. DOI:10.1007/978-14939-7571-6_31.</mixed-citation><mixed-citation xml:lang="en">Crupi R, Di Paola R, Esposito E, Cuzzocrea S. Middle cerebral artery occlusion by an intraluminal suture method. Methods Mol. Biol. 2018; 1727:393–401. DOI:10.1007/978-1-4939-7571-6_31.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Pontiki E., Hadjipavlou-Litina D. Multi-Target Cinnamic Acids for Oxidative Stress and Inflammation: Design, Synthesis, Biological Evaluation and Modeling Studies // Molecules. – 2018. – Vol. 24, №1(pii: E12). DOI:10.3390/molecules24010012.</mixed-citation><mixed-citation xml:lang="en">Pontiki E, Hadjipavlou-Litina D. Multi-Target Cinnamic Acids for Oxidative Stress and Inflammation: Design, Synthesis, Biological Evaluation and Modeling Studies. Molecules. 2018;24(1):12. DOI:10.3390/molecules24010012</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Chandra S., Roy A., Jana M., Pahan K. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model // Neurobiol Dis. 2019 Apr;124:379–395. DOI:10.1016/j.nbd.2018.12.007.</mixed-citation><mixed-citation xml:lang="en">Chandra S, Roy A, Jana M, Pahan K. Cinnamic acid activates PPARα to stimulate Lysosomal biogenesis and lower Amyloid plaque pathology in an Alzheimer’s disease mouse model. Neurobiol Dis. 2019; 124:379–395. DOI:10.1016/j.nbd.2018.12.007.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Miles E.A., Zoubouli P., Calder P.C., Phil D. Differential antiinflammatory effects of phenolic compounds from extra virgin olive identified in human whole blood cultures // Nutrition. – 2005. – Vol. 21, №3 – Р. 389–94. DOI: 10.1016/j.nut.2004.06.031.</mixed-citation><mixed-citation xml:lang="en">Miles EA, Zoubouli P, Calder PC, Phil D. Differential anti-inflammatory effects of phenolic compounds from extra virgin olive identified in human whole blood cultures. Nutrition. 2005; 21(3): 389–94. DOI: 10.1016/j.nut.2004.06.031.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Sánchez-Alonso I., Careche M., Moreno P., González M.J., Medina I. Testing caffeic acid as a natural antioxidant in functional fishfibre restructured products // LWT-Food Sci Technol. – 2011. – Vol. 44, №4. – Р. 1149–55. DOI: 10.1016/j.lwt.2010.11.018.</mixed-citation><mixed-citation xml:lang="en">Sánchez-Alonso I, Careche M, Moreno P, González MJ, Medina I. Testing caffeic acid as a natural antioxidant in functional fish-fibre restructured products. LWT-Food Sci Technol. 2011;44(4):1149– 55. DOI: 10.1016/j.lwt.2010.11.018.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Hudson E.A., Dinh P.A., Kokubun T., Simmonds M.S., Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells // Cancer Epidemiol Biomarkers Prev. – 2000. – Vol. 9, №11. – P. 1163–70.</mixed-citation><mixed-citation xml:lang="en">Hudson EA, Dinh PA, Kokubun T, Simmonds MS, Gescher A. Characterization of potentially chemopreventive phenols in extracts of brown rice that inhibit the growth of human breast and colon cancer cells. Cancer Epidemiol Biomarkers Prev. 2000;9(11):1163–70.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Ikeda K., Tsujimoto K., Uozaki M., Nishide M., Suzuki Y., Koyama A.H., et al. Inhibition of multiplication of herpes simplex virus by caffeic acid // Int J Mol Med. – 2011. – Vol. 28, №4. – P. 595–8. DOI: 10.3892/ijmm.2011.739.</mixed-citation><mixed-citation xml:lang="en">Ikeda K, Tsujimoto K, Uozaki M, Nishide M, Suzuki Y, Koyama AH, Yamasaki H. Inhibition of multiplication of herpes simplex virus by caffeic acid. Int J Mol Med. 2011;28(4): 595–8. DOI: 10.3892/ijmm.2011.739.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Chao C.Y., Mong M.C,. Chan K.C., Yin M.C. Anti-glycative and antiinflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice // Mol Nutr Food Res. – 2010. – Vol. 54, №3. – P. 388–95. DOI: 10.1002/mnfr.200900087.</mixed-citation><mixed-citation xml:lang="en">Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res. 2010;54(3): 388–95. DOI: 10.1002/mnfr.200900087.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Jung U.J., Lee M.K., Park Y.B., Jeon S.M., Choi M.S. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther. – 2006. – Vol. 318, №2. – P. 476–83. DOI: 10.1124/jpet.106.105163.</mixed-citation><mixed-citation xml:lang="en">Jung UJ, Lee MK, Park YB, Jeon SM, Choi MS. Antihyperglycemic and antioxidant properties of caffeic acid in db/db mice. J Pharmacol Exp Ther. 2006;318(2): 476–83. DOI: 10.1124/jpet.106.105163.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Zhang L., Zhang W.P., Chen K.D., Qian X.D., Fang S.H., Wei E.Q. Caffeic acid attenuates neuronal damage astrogliosis and glial scar formation in mouse brain with cryoinjury // Life Sci. – 2007. – Vol. 80, №6. – P. 530–537. DOI: 10.1016/j.lfs.2006.09.039.</mixed-citation><mixed-citation xml:lang="en">Zhang L, Zhang WP, Chen KD, Qian XD, Fang SH, Wei EQ. Caffeic acid attenuates neuronal damage astrogliosis and glial scar formation in mouse brain with cryoinjury. Life Sci. 2007; 80(6):530– 537. DOI: 10.1016/j.lfs.2006.09.039.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Altuğ M.E., Serarslan Y., Bal R., Kontaş T., Ekici F., Melek I.M., et al. Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: a biochemical and planimetric study // Brain Res. – 2008. – Vol. 1201. – P. 135– 42. DOI: 10.1016/j.brainres.2008.01.053.</mixed-citation><mixed-citation xml:lang="en">Altuğ ME, Serarslan Y, Bal R, Kontaş T, Ekici F, Melek IM, Аslan H, Duman T. Caffeic acid phenethyl ester protects rabbit brains against permanent focal ischemia by antioxidant action: a biochemical and planimetric study. Brain Res. 2008; 1201:135–42. DOI: 10.1016/j.brainres.2008.01.053.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Zhou Y., Fang S.H., Ye Y.L., Chu L.S., Zhang W.P., Wang M.L., et al. // Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin. – 2006. – Vol. 27, №9. – P. 1103–10. DOI: 10.1111/j.1745-7254.2006.00406.x.</mixed-citation><mixed-citation xml:lang="en">Zhou Y, Fang SH, Ye YL, Chu LS, Zhang WP, Wang ML, Wei EQ. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin. 2006; 27(9):1103– 10. DOI: 10.1111/j.1745-7254.2006.00406.x.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Fernandes F.H., Salgado H.R. Gallic Acid: Review of the Methods of Determination and Quantification // Crit Rev Anal Chem. – 2016. – Vol. 46, №3. – P. 257–65. DOI:10.1080/10408347.2015.1095064.</mixed-citation><mixed-citation xml:lang="en">Fernandes FH, Salgado HR. Gallic Acid: Review of the Methods of Determination and Quantification. Crit Rev Anal Chem. 2016; 46(3): 257–65. DOI:10.1080/10408347.2015.1095064.</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Воронков А.В., Поздняков Д.И., Нигарян С.А., Хури Е.И., Мирошниченко К.А., Сосновская А.В., Олохова Е.А. Оценка респирометрической функции митохондрий в условиях патологий различного генеза // Фармация и фармакология. – 2019. – Т. 7, №1. – С. 20–31. DOI:10.19163/2307-9266-2019-7-1-20-31.</mixed-citation><mixed-citation xml:lang="en">Voronkov AV, Pozdnyakov DI, Nigaryan SA, Khouri EI, Miroshnichenko KA, Sosnovskaya АV, Olokhova EA. Evaluation of the mitochondria respirometric function in the conditions of pathologies of various geneses. Pharmacy &amp; Pharmacology. 2019;7(1):20–31. DOI:10.19163/2307-9266-2019-7-1-20-31.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Voronkov A.V., Pozdnyakov D.I. Endothelotropic activity of 4-hydroxy-3, 5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia // Research Result: Pharmacology and Clinical Pharmacology. – 2018. – Vol. 4, №2. – Р. 1–10. DOI: 10.3897/rrpharmacology.4.26519.</mixed-citation><mixed-citation xml:lang="en">Voronkov AV, Pozdnyakov DI. Endothelotropic activity of 4-hydroxy-3, 5-di-tret-butylcinnamic acid in the conditions of experimental cerebral ischemia. Research Result: in Pharmacology. 2018; 4 (2):1–10. DOI: 10.3897/rrpharmacology.4.26519.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Тушмалова Н.А., Прагина Л.Л., Мальцева Е.Л., Воеводина Е.Б., Бурлакова Е.Б. Влияние малых доз Полидана на условный рефлекс пассивного избегания у крыс. The effect of small doses of Polidan on the conditioned reflex of passive avoidance in rats // Вестник Московского университета. – 2008. №4. – P. 3-7.</mixed-citation><mixed-citation xml:lang="en">Tushmalova NA, Pragina LL, Mal’ceva EL, Voevodina EB, Burlakova EB. Vliyanie malyh doz Polidana na uslovnyj refl s passivnogo izbeganiya u krys. [The effect of low doses of Polidan on the conditirefl x of passive avoidance in rats. The effect of small doses of Polidan on the conditi refl x of passive avoidance in rats]. Moscow University Biological Sciences Bulleti 2008; (4):3–7. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Воронков А.В., Абаев В.Т., Оганесян Э.Т., Поздняков Д.И. Изучение влияния субстанции ATACL на физическое и психическое состояние животных в условиях длительных истощающих нагрузок // Современные проблемы науки и образования. – 2015. – № 3.; URL: http://www.science-education.ru/ru/article/view?id=20331 (дата обращения: 04.01.2019).</mixed-citation><mixed-citation xml:lang="en">Voronkov AV, Abaev VT, Oganesyan ET, Pozdnyakov DI. Izuchenie vliyaniya substancii ATACL na fizicheskoe i psihicheskoe sostoyanie zhivotnyh v usloviyah dlitel’nyh istoshchayushchih nagruzok [Studying the effect of ATACL substance on the physical and mental state of animals under conditions of prolonged exhausting loads]. Modern problems of science and education. 2015;(3). Available at: http://www.science-education.ru/ru/article/view?id=20331 (date of the application: 04.01.2019). Russian.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Назарова Л.Е., Дьякова И.Н. Влияние кислоты феруловой на зону некроза, возникающего в результате окклюзии средней мозговой артерии. The effect of ferulic acid on the area of necrosis resulting from occlusion of the middle cerebral artery // Медицинский вестник Башкортостана. – 2011. №3. – P. 133–135.</mixed-citation><mixed-citation xml:lang="en">Nazarova LE, D’yakova IN. Vliyanie kisloty ferulovoj na zonu nekroza, voznikayushchego v rezul’tate okklyuzii srednej mozgovoj arterii [The effect of ferulic acid on the area of necrosis resulting from occlusion of the middle cerebral artery]. Bashkortostan Medical Journal.2011;(3):133–135. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lambertsen K.L., Finsen B., Clausen B.Н. Post-stroke inflammationtarget or tool for therapy? // Acta Neuropathologica. – 2018. – Р. 1–22. DOI: 10.1007/s00401-018-1930-z.</mixed-citation><mixed-citation xml:lang="en">Lambertsen KL, Finsen B, Clausen BН. Post-stroke inflammation-target or tool for therapy? Acta Neuropathologica. 2018; Р. 1–22. DOI: 10.1007/s00401-018-1930-z.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Султанов В.С., Зарубина И.В., Шабанов П.Д. Церебропротекторные и энергостабилизирующие эффекты полипренольного препарата ропрена при ишемии головного мозга у крыс // Обзоры по клин. фармаколологии и лекарственной терапии. – 2010. – Т. 8, № 3. – С. 31–47.</mixed-citation><mixed-citation xml:lang="en">Sultanov VS, Zarubina IV, SHabanov PD. Cerebroprotektornye i energostabiliziruyushchie effekty poliprenol’nogo preparata roprena pri ishemii golovnogo mozga u krys [Cerebroprotective and energy-stabilizing effects of the polyprenol preparation of ropren in rat cerebral ischemia]. Reviews on Clinical Pharmacology and Drug Therapy. 2010; 8(3): 31–47. Russian.</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Saito S., Takahashi Y., Ohki A., Shintani Y., Higuchi T. Early detection of elevated lactate levels in a mitochondrial disease model using chemical exchange saturation transfer (CEST) and magnetic resonance spectroscopy (MRS) at 7T-MRI // Radiol Phys Technol. – 2019. – Vol. 12, №1. – Р. 46–54. DOI:10.1007/s12194018-0490-1.</mixed-citation><mixed-citation xml:lang="en">Saito S, Takahashi Y, Ohki A, Shintani Y, Higuchi T. Early detection of elevated lactate levels in a mitochondrial disease model using chemical exchange saturation transfer (CEST) and magnetic resonance spectroscopy (MRS) at 7T-MRI. Radiol Phys Technol. 2019; 12(1): 46–54. DOI:10.1007/s12194-018-0490-1.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Оганесян Э.Т., Шатохин С.С., Глушко А.А. Использование квантово-химических параметров для прогнозирования антирадикальной (НО∙) активности родственных структур, содержащих циннамоильный фрагмент. I. Производные коричной кислоты, халкона и флавона // Фармация и фармакология. – 2019. – Т. 7, №1. – С. 53–66. DOI:10.19163/2307-9266-20197-1-53-66.</mixed-citation><mixed-citation xml:lang="en">Oganesyan ET., Shatokhin SS., Glushko AA. Using quantum-chemical parameters for predicting anti-radical (НО∙) activity of related structures containing a cinnamic mold fragment. i. derivatives of cinnamic acid, chalcon and flavanon. Pharmacy &amp; Pharmacology. 2019;7(1):53–66. DOI:10.19163/2307-9266-2019-7-1-53-66.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">He Y., Jia K., Li L., Wang Q., Zhang S., Du J., Du H. Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons // Biochem Biophys Res Commun. – 2018. – Vol. 498, №4. – Р. 1066–1072. DOI:10.1016/j.bbrc.2018.03.119.</mixed-citation><mixed-citation xml:lang="en">He Y, Jia K, Li L, Wang Q, Zhang S, Du J, Du H. Salvianolic acid B attenuates mitochondrial stress against Aβ toxicity in primary cultured mouse neurons. Biochem Biophys Res Commun. 2018; 498(4): 1066–1072. DOI:10.1016/j.bbrc.2018.03.119.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
